
About Navigating Cancer
Navigating Cancer is a Healthcare company based in Seattle (United States) founded in 2008. Patient engagement portal is provided for cancer patients health management. Navigating Cancer has raised $41.4 million across 4 funding rounds from investors including LabCorp, Western Technology Investment and Triple Tree. The company has 85 employees. Navigating Cancer offers products and services including Patient Engagement Portal and Health Tracker. Its focus areas include HealthTech, Healthcare IT, Value Based Care and Care Coordination. Its competitors include Thyme Care, Carevive and Cordata Healthcare Innovations; 3 of its 3 listed competitors have raised funding.
Company details
Navigating Cancer was founded in 2008 in Seattle, United States, within the healthcare sector focused on oncology. An online portal is operated to assist cancer patients with accessing disease information, participating in peer discussions, organizing personal health records, and monitoring medications and treatments. Connections to doctors and care providers are facilitated through the platform, supporting patient-centered care operations.
- Headquarters Seattle, United States
- Employees 85
- SectorsHealthcare
- Website navigatingcancer.com
- Social LinkedIn X Facebook
- Total Equity Funding$41.4M (USD)
in 4 rounds
- Latest Funding Round$26M (USD), Series D
Mar 2019
- InvestorsLabCorp
& 6 more
- Employee Count85
Products & Services of Navigating Cancer
Navigating Cancer offers a comprehensive portfolio of products and services, including Patient Engagement Portal and Health Tracker.
Secure portal for patient messaging and education in oncology care.
Tool for real-time symptom monitoring and remote patient management.
Funding Insights of Navigating Cancer
Navigating Cancer has successfully raised a total of $41.4M across 4 strategic funding rounds. The most recent funding activity was a Series D round of $26 million completed in March 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $41.4M
- Total Rounds 4
- Last Round Series D β $26M
- First Round $3.1M
(Oct 2011)
- Investors Count 7
All 4 funding rounds of Navigating Cancer with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2019 | $26M | Series D | β | Merck Global Health Innovation Fund, Triple Tree | |
| Aug 2015 | $10M | Series B | β | Merck Global Health Innovation Fund | |
| Sep 2012 | $2.3M | Series B | β | Western Technology Investment | β |
| Oct 2011 | $3.1M | Series B | β | Rustic Canyon Partners | β |
7 investors in total: 7 institutional.
Investors in Navigating Cancer
Navigating Cancer has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include LabCorp, Western Technology Investment and Triple Tree.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Corporate-backed venture capital is focused on the life science sector. | merckghifund.com | Kenilworth, United States | ||
BrightEdge is focused on impact investment in cancer care innovation. | brightedgefund.org | |||
ORIX USA is engaged in middle market asset management and lending. | orix.com | Dallas, United States | ||
| rusticcanyon.com | ||||
Venture debt is provided globally across multiple sectors. | 1980 | westerntech.com | Portola Valley, United States | |
Healthcare-focused investment banking services are offered by Triple Tree. | 1997 | triple-tree.com | Minneapolis, United States | |
Provider of laboratory tests for physicians | 1969 | labcorp.com | Burlington, United States |
Investor details for Navigating Cancer
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Navigating Cancer
14 people are tracked at Navigating Cancer (7 in leadership, 3 in board & advisors, 4 in team); the tracked headcount is 85.
| Name | Role | Group |
|---|---|---|
Sarah Croft | Director, Product Management | Leadership |
Roger Marckel | Director, Platform Services | Leadership |
Marsie Genetti | VP, Pharmaceutical Solutions | Leadership |
Michael Graff | Co-Founder & Chief Product Officer | Leadership |
Megan Murphy | Director, Business Development | Leadership |
Melissa Alexander | Director, Customer Experience | Leadership |
Mike Lachapelle | Director Of Provider Sales | Leadership |
Nosayaba Osazuwa-Peters | Medical Advisor | Board & advisors |
Ethan Basch | Medical Advisor | Board & advisors |
Debra Patt | Medical Advisor | Board & advisors |
Ryan Agro | Product Manager, Patient Monitoring | Team |
Aiza Abelon | Product Manager | Team |
Susan Esary | Senior Manager Client Services | Team |
Debra Secada | Patient Support Specialist / Patient Engagement Coordinator | Team |
Complete people profiles for Navigating Cancer
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Navigating Cancer
3 dated milestones of Navigating Cancer across 11 years, from founding to its latest funding, stage changes and deals.
- Founded Navigating Cancer is founded.
- Funding First funding round of $3.1M.
- Funding Latest funding round, Series D, of $26.0M.
Competitors of Navigating Cancer
Navigating Cancer has 3 listed competitors in our database, 3 of them funded. They include Thyme Care, Carevive and Cordata Healthcare Innovations.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| thymecare.com | 2020 | Nashville, United States | $400M | Provider of home nursing care services | ||
| carevive.com | 2013 | Philadelphia, United States | $25.25M | 29 | Provides personalized cancer care plans for patients | |
| cordatahealth.com | 2002 | Cincinnati, United States | $11.4M | 32 | Care coordination solutions for spine and oncology are provided. |
Detailed competitors of Navigating Cancer
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Navigating Cancer
The website of Navigating Cancer (navigatingcancer.com) receives about 6.4K visits a month.
- Monthly visits6.4K
▲ 59% vs previous month
Websites whose visitors overlap most with Navigating Cancer. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
cancercare.org | cancercare.org | 100% | #422,307 | β | |
cancer.net | cancer.net | 98% | #6,320,954 | β | |
cancersupportcommunity.org | cancersupportcommunity.org | 87% | #886,836 | β | |
medifocus.com | medifocus.com | 59% | β |
Top companies in Clinical IT & Data Platforms
3 companies that operate in the same segment as Navigating Cancer (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | |||
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | 1,746 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Navigating Cancer
Complete news archive for Navigating Cancer
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Navigating Cancer
Navigating Cancer was founded in 2008 and raised its 1st funding round 3 years after it was founded.
Navigating Cancer is headquartered in Seattle, United States. It is registered at Seattle, Washington, United States.
Navigating Cancer is a funded company, having raised a total of $41.4M across 4 funding rounds to date. The company's 1st funding round was a Series B of $3.1M, raised on Oct 2011.
Navigating Cancer has 85 employees.
Navigating Cancer was founded in 2008 in Seattle, United States, within the healthcare sector focused on oncology. An online portal is operated to assist cancer patients with accessing disease information, participating in peer discussions, organizing personal health records, and monitoring medications and treatments. Connections to doctors and care providers are facilitated through the platform, supporting patient-centered care operations.
Navigating Cancer's top competitors include Thyme Care, Carevive and Cordata Healthcare Innovations.
Navigating Cancer offers Patient Engagement Portal and Health Tracker.
Navigating Cancer has 7 investors. Key investors include LabCorp, Western Technology Investment, Triple Tree, Merck Global Health Innovation Fund, and BrightEdge.
